TD Cowen keeps USD 495 target for Elevance Health stock

Published on 10/26/2026 at 16:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter revenue reached USD 51.43 billion on October 21, 2026. Elevance Health stock costs EUR 387.35 on October 26, 2026 in Berlin trading.

Analyst target and quarterly revenue

TD Cowen maintained a Buy rating and a USD 495.00 target on October 23, 2026.
Third-quarter 2026 revenue reached USD 51.43 billion on October 21, 2026.
Elevance Health stock costs EUR 387.35 at Lang & Schwarz on October 26, 2026 at 4:29 p.m. CEST.

Elevance Health, US0367521038, Illustration mit AI erstellt.

Elevance Health stock (ISIN US0367521038) has a USD 495.00 target from TD Cowen, which maintained its Buy rating in a report dated October 23, 2026, according to Markets Insider. At Lang & Schwarz, the stock was trading at EUR 387.35 on October 26, 2026 at 4:29 p.m. CEST.

Revenue rose in the third quarter

Elevance Health reported third-quarter 2026 total revenue of USD 51.43 billion, up 1.40 percent from USD 50.71 billion in the third quarter of 2025. Shareholders' net income reached USD 1.37 billion, compared with USD 1.19 billion a year earlier, while diluted earnings per share rose to USD 6.27 from USD 5.32. The figures come from the company release distributed by Business Wire on October 21, 2026.

Carelon growth offsets membership pressure

Carelon operating revenue reached USD 19.30 billion in the third quarter of 2026, an increase of 5.00 percent from USD 18.30 billion in the third quarter of 2025. Its operating margin improved to 4.70 percent from 4.20 percent. Elevance Health's total medical membership fell to 44.88 million on September 30, 2026, from 45.37 million a year earlier, a decline of 1.10 percent.

Valuation and shareholder returns

The latest US quote places Elevance Health at a market capitalization of USD 93.8 billion and a trailing price-to-earnings ratio of 18.48 as of October 26, 2026. The 52-week range is USD 274.84 to USD 450.69. The company also declared a quarterly dividend of USD 1.72 per share on October 20, 2026, payable December 18, 2026, according to Business Wire.

What does the target imply?

TD Cowen's USD 495.00 target is USD 107.65 above the EUR 387.35 Lang & Schwarz quote, but the currencies differ and therefore do not support a percentage comparison. For investors, the more useful comparison is the operating split: Carelon expanded its margin while the Health Benefits segment posted a 1.00 percent margin in the third quarter of 2026.

Stock price and trading view

Elevance Health was trading at EUR 387.35 at Lang & Schwarz on October 26, 2026 at 4:29 p.m. CEST. The quote remains the central euro price for investors in Germany. The further course of trading is shown by the continuously updated real-time quote of Elevance Health stock.